Oluwakemi Onajin is a Dermatology physician affiliated with University of Chicago. OpenAlex indexes 32 publications with 371 citations (h-index 9).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
5841 S Maryland Ave
Chicago, IL 606371443
Telephone
888-824-0200Registry record last updated 24 Oct 2022.
Industry payments
5 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- AstraZeneca UK LimitedProgram year20256 payments
- UCB, Inc.Program year20251 payment
- Novartis Pharmaceuticals CorporationProgram year20243 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
31.5%Interleukin-17A Antagonist23.8%Cosentyx Unoready Pen100%Part D<11 patientsTNF inhibitor7.7%Inflectra100%Part D<11 patientsAnti-infectives
27.3%Azole Antifungal15.4%Ketoconazole100%Part D≥13 patientsTetracycline-class Drug11.9%Doxycycline Hyclate100%Part D≥13 patientsDermatology
23.8%Corticosteroid15.4%Triamcinolone Acetonide100%Part D≥14 patientsInterleukin-4 Receptor alpha Antagonist8.4%Dupixent Syringe100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Progressive Immunotherapy-Related Mucocutaneous Eruption: A Mimicker of SJS-TEN
American Journal of Dermatopathology
2025 - Successful Treatment of Severe Pyoderma Gangrenosum and Ulcerative Colitis With Upadacitinib
ACG Case Reports Journal
2024 - Advancements in Comorbidity Screening and Multidisciplinary Symptom Management for Hidradenitis Suppurativa
Current Dermatology Reports
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Everett Vokes, MD
University of Chicago
Ralph Weichselbaum, MD
University of Chicago
Mary Rinella, MD
University of Chicago
Hedy Kindler, MD
University of Chicago
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”